Contract Options

[Anonymous]

Given the imminent downsizing that will occur or termination of the Mallinckrodt/Ventiv contract altogether, why not allow reps to volunteer to move to another contract now?

Reps were recruited under the premise that this would be a 3-5 year contract, there would be new medications to launch, that XXR would have abuse deterrence labeling to differentiate it from generics, that the average bonus would be $26k etc. etc.,

The reality, no abuse deterrent language in the label, XXR launch delayed, Exalgo goes away, Pennsaid 2% (the best drug in the bag) loses promo rights, no pharmacy stocking plan up front and major gaps still exist, huge gaps in commercial formulary coverage with no Medicare or Medicaid coverage, inaccurate target lists from ZS that change every quarter, substandard sales aids, no significant clinical studies to differentiate XXR, MNK 155 to be schedule II, -- bottom line...reps are not at fault given the management and marketing blunders.

Ventiv knows where the blame lies so why not ease the pain by giving Mallinckrodt their reduced headcount by allowing reps to transition to other contract opportunities without the drama of a mass layoff?

 

[Anonymous]

Completely agree! Only exception is I feel the marketing materials are well put together; they just got the targeting wrong and haven't caught up. At this point, we should have a piece for plastic surgeons, one for oral surgeons, one for surgery centers, a few for orthopedic surgeons, etc. They should be pieces that connect with clinic managers and other gate keepers to help them understand. "For your referral patients" doesn't exactly resonate!

 

[Anonymous]

Agreed this place sucks so just go find another job and shut the fuck up already!

 

[Anonymous]

Ya pays ya money, and ya takes ya chances.

Get over it.

 

[Anonymous]

Given the imminent downsizing that will occur or termination of the Mallinckrodt/Ventiv contract altogether, why not allow reps to volunteer to move to another contract now?

Reps were recruited under the premise that this would be a 3-5 year contract, there would be new medications to launch, that XXR would have abuse deterrence labeling to differentiate it from generics, that the average bonus would be $26k etc. etc.,

The reality, no abuse deterrent language in the label, XXR launch delayed, Exalgo goes away, Pennsaid 2% (the best drug in the bag) loses promo rights, no pharmacy stocking plan up front and major gaps still exist, huge gaps in commercial formulary coverage with no Medicare or Medicaid coverage, inaccurate target lists from ZS that change every quarter, substandard sales aids, no significant clinical studies to differentiate XXR, MNK 155 to be schedule II, -- bottom line...reps are not at fault given the management and marketing blunders.

Ventiv knows where the blame lies so why not ease the pain by giving Mallinckrodt their reduced headcount by allowing reps to transition to other contract opportunities without the drama of a mass layoff?

Sorry to hear.
Glad i left in july from the Ventiv contract. It was obvious that the product was not going to sell. Worst experience in my pharma career. The MNk manager was a complete bitch and disrespectful. I am glad that i cruised the last few weeks and left and never looked back. Complete shit and the most egregious treatment of reps in history.
If you were anti union before this place is a great reason why employees need a union. to protect them from this horrible behavior from this greedy company